Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Allergy Clin Immunol. 2014 Oct 11;135(2):386–394.e5. doi: 10.1016/j.jaci.2014.08.023

Figure 2.

Figure 2

A. Proportion of traditional disease severities by molecular subgroups defined by BAL IL-27 mRNA and epithelial CCL26 mRNA. B. Baseline FEV1 percent predicted among groups by BAL IL-27 and epithelial CCL26. C, Relative CXCL9 mRNA on log scale in freshly brushed epithelial cells among groups by BAL IL-27 and epithelial CCL26.